291 related articles for article (PubMed ID: 15452155)
1. The prognostic value of progesterone receptor status in meningiomas.
Roser F; Nakamura M; Bellinzona M; Rosahl SK; Ostertag H; Samii M
J Clin Pathol; 2004 Oct; 57(10):1033-7. PubMed ID: 15452155
[TBL] [Abstract][Full Text] [Related]
2. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
3. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG
Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437
[TBL] [Abstract][Full Text] [Related]
5. The impact of progesterone receptor expression on relapse in the long-term clinical course of 93 benign meningiomas.
Strik HM; Strobelt I; Pietsch-Breitfeld B; Iglesias-Rozas JR; Will B; Meyermann R
In Vivo; 2002; 16(4):265-70. PubMed ID: 12224136
[TBL] [Abstract][Full Text] [Related]
6. Progesterone and estrogen receptors in meningiomas: prognostic considerations.
Hsu DW; Efird JT; Hedley-Whyte ET
J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical expression of progesterone receptor in relationship with histological grade and risk of relapses in intracranial meningiomas].
Hernández Faraco A; Céspedes G; Trejo E
Neurologia; 2009 May; 24(4):235-44. PubMed ID: 19603293
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
9. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
[TBL] [Abstract][Full Text] [Related]
11. S100A5: a marker of recurrence in WHO grade I meningiomas.
Hancq S; Salmon I; Brotchi J; De Witte O; Gabius HJ; Heizmann CW; Kiss R; Decaestecker C
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):178-87. PubMed ID: 15043715
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
13. [Proliferative markers of meningiomas: immunohistochemical analysis and prognostic value].
Korshunov AG; Shishkina LV; Golanov AV
Arkh Patol; 2002; 64(1):29-33. PubMed ID: 11889696
[TBL] [Abstract][Full Text] [Related]
14. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM
Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
[TBL] [Abstract][Full Text] [Related]
15. Parasagittal meningiomas: follow-up review.
Colli BO; Carlotti CG; Assirati JA; Dos Santos MB; Neder L; Dos Santos AC
Surg Neurol; 2006; 66 Suppl 3():S20-7; discussion S27-8. PubMed ID: 17081848
[TBL] [Abstract][Full Text] [Related]
16. [Report of seven cases of clear-cell meningioma and a literature review].
Rousselot C; Francois P; Jan M; Bergemer AM
Ann Pathol; 2010 Apr; 30(2):73-82. PubMed ID: 20451062
[TBL] [Abstract][Full Text] [Related]
17. Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone.
Maillo A; Orfao A; Espinosa AB; Sayagués JM; Merino M; Sousa P; Lara M; Tabernero MD
Neuro Oncol; 2007 Oct; 9(4):438-46. PubMed ID: 17704362
[TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor expression in meningiomas.
Carroll RS; Glowacka D; Dashner K; Black PM
Cancer Res; 1993 Mar; 53(6):1312-6. PubMed ID: 8443810
[TBL] [Abstract][Full Text] [Related]
19. Does protein expression predict recurrence of benign World Health Organization grade I meningioma?
Kärjä V; Sandell PJ; Kauppinen T; Alafuzoff I
Hum Pathol; 2010 Feb; 41(2):199-207. PubMed ID: 19801161
[TBL] [Abstract][Full Text] [Related]
20. Primary resected meningiomas: relapses and proliferation markers.
Kalala JP; Caemaert J; De Ridder L
In Vivo; 2004; 18(4):411-6. PubMed ID: 15369177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]